Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43026 (
lipopolysaccharide
)
62,215
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Reactive AA amyloidosis can be induced in mice in a model of sustained inflammation following daily casein subcutaneous injections. However, the development of AA amyloidosis is known to vary in different strains of mice. The C57BL/6 strain is susceptible to the development of amyloidosis while the A/J strain is resistant. The degradation of purified
serum amyloid A
(
SAA
) protein by human monocytes as well as by mouse macrophages has been shown. The resistance/susceptibility of different mouse strains to the development of systemic amyloidosis may therefore be related to a difference in the ability of macrophages to degrade
SAA
. The authors have used bone marrow-derived macrophage cell lines obtained from susceptible C57BL/6 (ANA-1) and resistant A/J (A/J 10) mouse strains to compare their ability to degrade HDL-
SAA
in vitro. Cells were incubated with HDL-
SAA
for up to 72 h and the culture medium was analysed by SDS-PAGE to determine the rate of
SAA
degradation by the macrophages. The A/J 10 cells (resistant) were found to initiate a constant HDL-
SAA
degradation promptly whereas ANA-1 cells (susceptible) showed an intermittent block in the degradation of the precursor. Activation of macrophages by
lipopolysaccharide
(
LPS
) or interferon-gamma (IFN-gamma) hampered the precursor degradation suggesting that the activation process may favour extracellular accumulation of the precursor leading to a partial degradation and fibril formation.
...
PMID:Degradation of amyloid A precursor protein SAA by macrophage cell lines obtained from amyloid resistant and susceptible strains of mice. 910 21
To learn about the effects of chronic exposure to IL-1 we generated a transgenic (Tg) mouse line that expresses human IL-1 beta under the control of the lens alpha-A crystallin promoter. Expression of human IL-1 beta was restricted to the eye; neither the protein nor its mRNA were detected in various other organs of the Tg mice. The Tg mice develop severe ocular inflammation shortly after birth, which affects the lens and other eye tissues and apparently allows the release of IL-1 into the circulation. Here we report that the Tg mice exhibit decreased responsiveness to IL-1 and
lipopolysaccharide
(
LPS
), as compared to their wild-type littermate controls: (1) when injected with IL-1 the Tg mice produced lower levels of
serum amyloid A
than their controls; (2) thymocytes of the Tg mice responded less vigorously in culture to stimulation with IL-1; and (3) Tg mice showed lower morbidity and mortality than their controls when injected with toxic amounts of
LPS
. These data suggest that chronic exposure to IL-1 in the Tg mice induces partial resistance to this cytokine, analogous to the reduced responsiveness to IL-1 in animals pretreated with this proinflammatory cytokine.
...
PMID:Reduced susceptibility to IL-1 and endotoxin in transgenic mice expressing IL-1 in their lens. 916 17
To investigate if leptin shares in vivo activities with interleukin (IL)-6 family cytokines, it was tested in normal mice for the ability, after a single injection, to induce the acute-phase protein
serum amyloid A
, to potentiate the induction by IL-1 of serum corticosterone and IL-6, and to inhibit the induction by
lipopolysaccharide
of serum tumor necrosis factor and, after seven daily injections, to cause body weight loss and to change peripheral blood cell counts. At a 0.5 mg/kg dose, leptin caused body weight loss but did not show any of the other activities above. At a dose of 5 mg/kg, which also caused body weight loss, leptin potentiated the induction by IL-1 of serum corticosterone and IL-6 but did not show any other activity. In addition to causing body weight loss, leptin shows only some of the in vivo activities typical of IL-6 family cytokines and only if used at a dose that exceeds the one sufficient to affect body weight. In vivo, leptin seems to chiefly control body weight and not inflammatory or hematopoietic processes.
...
PMID:Leptin causes body weight loss in the absence of in vivo activities typical of cytokines of the IL-6 family. 972 91
We examined the effect of endotoxemia in mice on protein and mRNA levels for the acute phase proteins complement C3 and
serum amyloid A
(
SAA
) in jejunal mucosa. Endotoxemia was induced in mice by the subcutaneous injection of 250 microg
lipopolysaccharide
per mouse. Control mice were injected with saline. C3 and
SAA
were measured by ELISA. Messenger RNA levels were determined by Northern blot analysis or competitive PCR. Immunohistochemistry was performed to determine in which cell type(s) C3 and
SAA
were present. Mucosal C3 and SAA protein and mRNA levels were increased in endotoxemic mice. Immunohistochemistry showed that C3 was present in both enterocytes and cells of the lamina propria, whereas
SAA
was seen mainly in lamina propria cells. Results suggest that endotoxemia stimulates production of C3 and
SAA
in small intestinal mucosa. The response may be regulated at the transcriptional level and probably reflects increased synthesis of the acute phase proteins in both enterocytes and cells of the lamina propria.
...
PMID:Endotoxemia in mice stimulates production of complement C3 and serum amyloid A in mucosa of small intestine. 979 Oct 77
Oncostatin M (OM) is a member of the interleukin-6 (IL-6) cytokine subfamily. The binding of OM to its receptor initiates signal transduction through JAK-signal transducers and activators of transcription (STAT) pathways and activates transcription activators through mitogen-activated protein (MAP) kinases. Results of in vitro assays documented that OM modulates cytokine expression and alters the production of proteases that down-regulate inflammation. Administration of OM to
lipopolysaccharide
(
LPS
)-challenged mice lowered serum tumor necrosis factor-alpha (TNF-alpha) levels and decreased the lethal effects of
LPS
administration. OM also reduced inflammation in animal models of human disease, including inflammatory bowel disease, antibody-induced arthritis, and experimental autoimmune encephalomyelitis. Preclinical safety studies have been conducted in the mouse and monkey. Mice were administered OM (subcutaneously) at 72, 360, or 1,560 micrograms/kg/day in a 2-wk toxicity study. Decreased body weights occurred at 1,560 micrograms/kg. Drug-related changes at 360 and 1,560 micrograms/kg consisted of dermal irritation at the injection site, leukopenia, and thymic lymphoid depletion; all changes were reversible following a 2-wk recovery period. In a 2-wk subcutaneous study in monkeys, OM was administered at 1, 5, 15, 45, or 150 micrograms/kg/day. At all doses there was reversible, transient inappetence and dermal irritation at the injection site. Drug-related changes at 5, 15, 45, and 150 micrograms/kg consisted of reversible elevations in both
serum amyloid A
and IL-6, and reversible thymic lymphoid depletion. Transient increases in body temperature occurred at 15, 45, and 150 micrograms/kg. The observed spectrum of immunomodulatory effects suggests that OM may have therapeutic utility in treating chronic inflammatory diseases.
...
PMID:Oncostatin M: development of a pleiotropic cytokine. 1020 78
Serum amyloid A (
SAA
) is an acute phase protein of unknown function that is involved in systemic amyloidosis and may also be involved in atherogenesis. The precise role of
SAA
in these processes has not been established.
SAA
circulates in plasma bound to high density lipoprotein-3 (HDL3). The pathway for the production of
SAA
-containing HDL is not known. To test whether apolipoprotein (apo)A-I-HDL is required in the production of
SAA
-HDL, we analyzed the
lipopolysaccharide
(
LPS
)-induced changes in apoA-I+/+ and apoA-I-/- mice. In apoA-I+/+ mice, after injection of
LPS
, remodeling of HDL occurred: total cholesterol increased and apoA-I decreased slightly and shifted to lighter density. Dense (density of HDL3) but large (size of HDL2 )
SAA
-containing particles were formed. Upon fast phase liquid chromatography fractionation of plasma, >90% of
SAA
eluted with HDL that was enriched in cholesterol and phospholipid and shifted "leftward" to larger particles. Non-denaturing immunoprecipitation with anti-mouse apoA-I precipitated all of the apoA-I but not all of the
SAA
, confirming the presence of
SAA
-HDL devoid of apoA-I. In the apoA-I-/- mice, which normally have very low plasma lipid levels,
LPS
injection resulted in significantly increased total and HDL cholesterol. Greater than 90% of the
SAA
was lipid associated and was found on dense but large, spherical HDL particles essentially devoid of other apolipoproteins.We conclude that
serum amyloid A
(
SAA
) is able to sequester lipid, forming dense but large HDL particles with or without apoA-I or other apolipoproteins. The capacity to isolate lipoprotein particles containing
SAA
as the predominant or only apolipoprotein provides an important system to further explore the biological function of
SAA
.
...
PMID:SAA-only HDL formed during the acute phase response in apoA-I+/+ and apoA-I-/- mice. 1035 41
To determine why germfree mice are less susceptible to
lipopolysaccharide
(
LPS
) than conventional mice, we studied serum levels of
serum amyloid A
(
SAA
), tumor necrosis factor (TNF), interleukin 1 (IL-1), IL-6, and corticosterone in mice after treatment with
LPS
. A single injection of
LPS
caused an elevation of
SAA
, an acute-phase protein in the mouse, in both conventional and germfree IQI mice, and the response was significantly less in germfree mice.
LPS
-induced elevations of serum TNF, IL-1, and IL-6 levels were also significantly less in germfree mice, while serum corticosterone levels were greater in germfree mice than in conventional mice. These results suggest that the lower susceptibility to
LPS
and a smaller response of
SAA
elevation by
LPS
in germfree mice may result from less elevation in serum of these cytokines in these mice, which are known to mediate the acute phase response of
SAA
. High levels of serum corticosterone in germfree mice may be partly responsible for the lower responsiveness of these inflammatory cytokines to
LPS
in these mice.
...
PMID:Serum amyloid A, cytokines, and corticosterone responses in germfree and conventional mice after lipopolysaccharide injection. 1042 85
The effect of endotoxemia and sepsis on mucosal production of the acute-phase proteins complement component C3 and
serum amyloid A
(
SAA
) was studied in mice. In addition, the role of the proinflammatory cytokines tumor necrosis factor-alpha, interleukin (IL)(-1)beta, and IL-6 on mucosal C3 and
SAA
production was examined. Endotoxemia was induced by the subcutaneous injection of 250 microg/mouse of
lipopolysaccharide
. Control mice were injected with corresponding volumes of sterile saline solution. Sepsis was induced by cecal ligation and puncture, and sham-operated mice served as controls. Endotoxemia resulted in increased mucosal C3 levels in all parts of the gastrointestinal tract examined, from the stomach to the colon, with the most pronounced effects noticed in the proximal gastrointestinal tract. The influence of endotoxemia on mucosal
SAA
production was more differentiated with increased levels noted in the jejunum and ileum, and no changes seen in gastric and colonic mucosa. Sepsis resulted in similar changes in mucosal C3 and
SAA
levels as seen in endotoxemic mice, except that
SAA
levels were increased in colonic mucosa of septic mice. Among the cytokines, IL(-1)beta resulted in the most pronounced changes in mucosal acute-phase proteins. The increase in C3 and
SAA
levels in the mucosa of the small intestine during endotoxemia was partially blocked by IL(-1) receptor antagonist. The results suggest that endotoxemia is associated with increased mucosal C3 production in different parts of the gastrointestinal tract and increased
SAA
production in the mucosa of the small intestine. Mucosal acute-phase protein synthesis may, at least in part, be regulated by IL(-1)beta.
...
PMID:Mucosal production of complement C3 and serum amyloid A is differentially regulated in different parts of the gastrointestinal tract during endotoxemia in mice. 1045 12
Enzyme-linked immunosorbent assay (ELISA) methods for measuring murine
serum amyloid A
(
SAA
), a representative acute phase reactant, were developed utilizing a newly produced monoclonal antibody. Two site-ELISA, in which the monoclonal antibody was used as the captured antibody, was sensitive enough to determine the
SAA
concentration in mice at the steady state. Direct binding ELISA, in which the sample
SAA
bound to the plastic wells was detected by the antibody, was simple and suitable for measuring the elevated
SAA
, but could not analyze the resting level of
SAA
because of the need for high dilution in plasma samples. Plasma
SAA
concentrations were measured in ten ICR mice on the day of purchase and at the end of seven days of ordinary rearing. The
SAA
concentration of one animal decreased from 1.6 to 0.5 mg/l during a week, while the others had no obvious changes. The plasma
SAA
of the ten animals after one week of rearing ranged from 0.3 to 0.8 mg/l with a mean of 0.47. These mice, two days after 10 microg
lipopolysaccharide
were given, had increased
SAA
values up to a mean of 300 mg/l, though with variations between animals.
...
PMID:Monoclonal antibody-based sensitive enzyme-linked immunosorbent assay for murine serum amyloid A. 1059 56
Most in vivo studies demonstrating decreased activities of hepatic cytochromes P450 with inflammation have used Gram-negative bacterial
lipopolysaccharide
(
LPS
) as the inflammatory stimulant. But products of Gram-positive bacteria, such as staphylococcal enterotoxin B (SEB), also stimulate inflammatory mediators, albeit with a different pattern than
LPS
. Therefore, effects of SEB on the regulation of murine constitutive P450s were determined in this study and compared with those of
LPS
.
LPS
-responsive C3H/HeN and
LPS
-unresponsive C3H/HeJ mice were injected with either
LPS
(0.5 mg/kg) or SEB (0.66 to 6.6 mg/kg), and hepatic cytochromes P450 and serum tumor necrosis factor-alpha, interleukin-6, nitrate/nitrite, and
serum amyloid A
concentrations were determined up to 24 hr. HeJ mice were generally less responsive than HeN mice to both stimuli, with lower cytokine, nitrate/nitrite, and
serum amyloid A
responses. However, in both mouse strains SEB caused more prolonged cytokine, higher nitrate/nitrite, and lower
serum amyloid A
concentrations than
LPS
. Despite these differences, in HeN mice, after both SEB and
LPS
administration, total P450 concentrations were equally depressed by 40%. Both SEB and
LPS
depressed CYP1A1 and 1A2 microsomal protein concentrations by 45 and 30%, respectively; CYP2E1 by 64%; and CYP3A by 70%. There was comparable inhibition of enzymatic activities. In HeJ mice, SEB was only slightly more effective in depressing P450s than
LPS
, as might be expected. These data showed that the Gram-positive bacterial inflammatory stimulant SEB caused effects on murine hepatic cytochromes P450 similar to those of
LPS
, even though the pattern of inflammatory mediators induced after SEB exposure was different.
...
PMID:Depression of constitutive murine cytochromes P450 by staphylococcal enterotoxin B. 1073 30
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>